Equities
  • Price (EUR)0.284
  • Today's Change0.006 / 2.16%
  • Shares traded5.00k
  • 1 Year change+381.36%
  • Beta0.1068
Data delayed at least 15 minutes, as of Feb 16 2026 07:01 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Key statistics

Starpharma Holdings Ltd (PQ6:HAM) set a new 52-week high during today's trading session when it reached 0.284. Over this period, the share price is up 377.31%.
52-week range
Today
0.025Jul 28 20250.284Feb 16 2026
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open0.284
High0.284
Low0.284
Bid0.284
Offer0.312
Previous close0.278
Average volume0.00
Shares outstanding419.92m
Free float343.97m
P/E (TTM)--
Market cap205.76m AUD
EPS (TTM)-0.024
AUD
Data delayed at least 15 minutes, as of Feb 16 2026 07:01 GMT.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.